Completed NA INTERVENTIONAL 3-arm NCT03970850

NeuMoDx PrEDiCTiNG Study Evaluation Plan

Multi-Center Clinical Performance Evaluation of the NeuMoDx™ Chlamydia Trachomatis (CT) / Neisseria Gonorrhoeae (NG) [CT/NG] Assay on the NeuMoDx™ 288 Molecular System and the NeuMoDx™96 Molecular System

Sponsor: NAMSA

Conditions Chlamydia Trachomatis Infection Neisseria Gonorrheae Infection

Interventions FDA-cleared NAATs NeuMoDx CT/NG Assay

Updated 9 times since 2019 Last updated: Jun 11, 2020 Started: Jul 22, 2019 Primary completion: Feb 25, 2020 Completion: Feb 25, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03970850, this NA trial focuses on Chlamydia Trachomatis Infection and Neisseria Gonorrheae Infection and remains completed. Sponsored by NAMSA, it has been updated 9 times since 2019, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jul 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 4 earlier versions

Apr 2020 — Jul 2020 [monthly]

Recruiting NA
Feb 2020 — Apr 2020 [monthly]

Recruiting NA
Sep 2019 — Feb 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jul 2019 — Sep 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NAMSA
NeuMoDx Molecular, Inc.

Data source: NeuMoDx Molecular, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Ann Arbor, United States , Birmingham, United States , Charleston, United States , Cleveland, United States , Detroit, United States , Elizabeth, United States , Houston, United States , Indianapolis, United States , New Orleans, United States and 5 more locations